“[...] PHA is a rare yet aggressive mesenchymal tumor of the liver, which requires a multi-disciplinary approach to achieve the best patient outcomes.” “In our ...
A previous version of this article appeared on Targeted Oncology ™. Although immunotherapy has become a mainstay of treatment for various types of cancer, it has been less successful in treating ...